Painful Channelopathies Study
Unknown statusNCT02696746
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
To understand the pathophysiological basis of heritable pain syndromes. This will consist of a number of components: * Determine the genetic basis for heritable pain syndromes. * Investigate the pain symptoms, psychological co-morbidity and quality of life in patients with heritable pain syndromes. * Use quantitative sensory testing to investigate abnormalities in sensory processing. * Use imaging modalities to investigate the neural correlates of pain perception in heritable channelopathies. * In select patients to perform skin biopsy to determine if there has been any damage to C-fibres. * To perform skin biopsy in order to culture fibroblasts and neural crest stem cells for future studies into the molecular basis of altered pain perception. * To use neurophysiological tests, the axon reflex, and conditioning challenges to determine how peripheral nerves, in heritable channelopathies and unusual pain syndromes, have been altered. * Microneurographic recordings for directly detecting the function of pain fibres in peripheral nerves. Knowledge gained from the study will be used to aid the further development of genetic testing and specific pain questionnaires for the diagnosis of heritable pain syndromes secondary to channelopathies. * Ultimately better knowledge of underlying pathophysiology in these heritable pain conditions may inform the development of novel treatments.
Study details
- Official title
- Painful Channelopathies Study
- Conditions
- Erythromelalgia
- Pain Insensitivity, Congenital
- Hereditary Sensory and Autonomic Neuropathies
- Chronic Pain
- Interventions
- Sponsor
- King's College London
- Collaborators
- University of Oxford; Neuroscience Technologies S.L.P
- Start date
- 2012-02
- Primary completion
- 2021-06
- Sex
- All
- Age range
- from 18 Years to 99 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- United Kingdom
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients who are ≥16 years of age who have a set of symptoms that resemble those seen on Paroxysmal Extreme Pain Disorder, Familial Episodic Pain Syndrome or Erythromelalgia. * Patients already with the diagnosis of Paroxysmal Extreme Pain Disorder or Familial Episodic Pain Syndrome or Erythromelalgia. * Patients with reduced pain sensibility. * First degree relatives of patients who meet diagnostic criteria for Paroxysmal Extreme Pain Disorder, Familial Episodic Pain Syndrome, Erythromelalgia or inability to experience pain. * Patients who do not fulfill any of the exclusion criteria. Exclusion Criteria: * Pregnant subjects. * Subjects with insufficient command of English to obtain consent from or to complete the study questionnaires. * Subjects with insufficient mental capacity to obtain consent from or to complete the study questionnaires. * Subjects with concurrent severe psychological or psychiatric disorders, specially those patients with severe claustrophobia. * Patients with moderate to severe pain arising as a consequence of other disorders causing pain but that are not associated with those mentioned before as channelopathies. * Patients with central nervous system diseased that may complicate the somatosensory testing. * The skin biopsy procedure, will not be conducted on those patients with contraindications to do so i.e. anticoagulation therapy, skin infections, etc; that might result in adverse outcomes (if the subject decides to decline the skin biopsy, the inclusion on the study will not be affected). * The functional magnetic resonance imaging (fMRI) component will not be performed in subjects that had medical interventions with any device likely to be damaged or moved from its place, at any moment during the fMRI scanning procedure (including cerebral coils or clips, heart pacemakers or defibrillators, heart valve prosthesis, medicine infusion pumps, inner ear implants, neural stimulators, brain shunts, joint replacements/ large metal implants, stents in the heart or arteries, some implants, or some intra-uterine contraceptive devices. * Those patients that in the concept of the research team unsuitable for participation in the study. * For those undergoing microneurography presence of edema (swelling) or any skin condition at the ankle level that may interfere with the microneurography procedure. * Patients with a history of skin allergy or sensitivity will not undergo testing of axon reflex or conditioning challeng…
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02696746